Skip to main content
    B

    Becton Dickinson and Company (BDX)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE

    $193.85
    +4.96 (+2.63%)

    Market Cap: $51.45B

    Last updated: Oct 16, 2026 at 1:54 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    97%(38/39)
    Avg Surprise
    +6.18%
    Streak
    11 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$3.90
    Range$3.27 - $3.97
    15 analysts
    Revenue Consensus
    $4.6B
    Range$4.5B - $4.6B
    8 analysts
    Period ending Dec 31, 2026
    EPS Consensus$2.74
    Range$2.60 - $3.01
    10 analysts
    EPS Revisions
    1
    0
    7d
    0
    7
    30d
    EPS Estimate DriftChange to current
    90d ago$2.80-2.2%
    60d ago$2.73+0.4%
    30d ago$2.73+0.3%
    7d ago$2.73+0.3%
    Current$2.74
    Revenue Consensus
    $4.6B
    Range$4.5B - $4.6B
    8 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$2.74---
    Sep 26EST
    		-$3.90---
    Jun 26
    Reported Aug 6
    		$3.23$3.14+2.87%Beat-12.2%
    Mar 26
    Reported May 7
    		$2.90$2.77+4.69%Beat-13.4%
    Dec 25
    Reported Feb 9
    		$2.91$2.80+3.93%Beat-15.2%
    Sep 25
    Reported Nov 6
    		$3.96$3.91+1.28%Beat+3.9%
    Jun 25
    Reported Aug 7
    		$3.68$3.42+7.60%Beat+5.1%
    Mar 25
    Reported May 1
    		$3.35$3.28+2.13%Beat+5.7%
    Dec 24
    Reported Feb 5
    		$3.43$2.99+14.72%Beat+28.0%
    Sep 24
    Reported Nov 7
    		$3.81$3.77+1.06%Beat+11.4%
    Jun 24
    Reported Aug 1
    		$3.50$3.31+5.74%Beat+18.2%
    Mar 24
    Reported May 2
    		$3.17$2.97+6.73%Beat+10.8%
    Dec 23
    Reported Feb 1
    		$2.68$2.40+11.67%Beat-10.1%
    Sep 23
    Reported Nov 9
    		$3.42$3.43-0.29%Miss+24.4%
    Jun 23
    Reported Aug 3
    		$2.96$2.91+1.72%Beat+11.3%
    Mar 23
    Reported May 4
    		$2.86$2.75+4.00%Beat-10.1%
    Dec 22
    Reported Feb 2
    		$2.98$2.68+11.19%Beat-18.1%
    Sep 22
    Reported Nov 10
    		$2.75$2.74+0.36%Beat+6.2%
    Jun 22
    Reported Aug 4
    		$2.66$2.50+6.40%Beat-2.9%
    Mar 22
    Reported May 5
    		$3.18$2.95+7.80%Beat-0.3%
    Dec 21
    Reported Feb 3
    		$3.64$2.85+27.72%Beat-20.0%
    Sep 21
    Reported Nov 4
    		$2.59$2.45+5.71%Beat-7.2%
    Jun 21
    Reported Aug 5
    		$2.74$2.44+12.30%Beat+24.5%
    Mar 21
    Reported May 6
    		$3.19$3.04+4.93%Beat+25.1%
    Dec 20
    Reported Feb 4
    		$4.55$3.16+43.99%Beat+71.7%
    Sep 20
    Reported Nov 5
    		$2.79$2.54+9.84%Beat-15.7%
    Jun 20
    Reported Aug 6
    		$2.20$2.07+6.28%Beat-28.6%
    Mar 20
    Reported May 7
    		$2.55$2.29+11.35%Beat-1.5%
    Dec 19
    Reported Feb 6
    		$2.65$2.64+0.38%Beat-1.9%
    Sep 19
    Reported Nov 5
    		$3.31$3.31+0.00%Beat+13.0%
    Jun 19
    Reported Aug 6
    		$3.08$3.06+0.65%Beat+5.8%
    Mar 19
    Reported May 9
    		$2.59$2.59+0.00%Beat-2.3%
    Dec 18
    Reported Feb 5
    		$2.70$2.62+3.05%Beat+8.9%
    Sep 18
    Reported Nov 6
    		$2.93$2.93+0.00%Beat+22.1%
    Jun 18
    Reported Aug 2
    		$2.91$2.86+1.75%Beat+18.3%
    Mar 18
    Reported May 3
    		$2.65$2.63+0.76%Beat+15.2%
    Dec 17
    Reported Feb 6
    		$2.48$2.41+2.90%Beat+6.4%
    Sep 17
    Reported Nov 2
    		$2.40$2.37+1.27%Beat-
    Jun 17
    Reported Aug 3
    		$2.46$2.44+0.82%Beat-
    Mar 17
    Reported May 2
    		$2.30$2.23+3.14%Beat-
    Dec 16
    Reported Feb 2
    		$2.33$2.11+10.43%Beat-

    Dividends

    Dividend Metrics

    Forward Yield2.17%
    Forward Annual Dividend$4.20
    Payout Ratio27.37%
    FrequencyQuarterly
    Pay MonthsMar, Jun, Sep, Dec

    Growth

    3Y CAGR+5.81%
    5Y CAGR+5.44%
    BDX dividend history and ex-dividend datesRun BDX in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio14.91EV/EBITDA14.32x
    Price/FCF16.49xFCF Yield6.07%
    Profitability
    Profit Margin4.19%Operating Margin15.70%
    ROE6.61%ROIC4.99%
    Financial Health
    Debt/Equity0.69xInterest Coverage4.00x
    Current Ratio0.87xQuick Ratio0.51x
    Trading Statistics
    Beta0.28Avg Volume1.81M
    52-Week High$191.9452-Week Low$124.47

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$184.34
    SMA 20$182.83
    SMA 50$183.09
    SMA 200$162.61
    EMA 10$186.20
    EMA 20$184.11
    EMA 50$179.55
    EMA 200$164.65

    MACD

    Line: 2.24Signal: 1.06Hist: 1.18

    ADX

    ADX: 22.7+DI: 35.4-DI: 14.0

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down4.0
    PSAR$178.61

    Bollinger Bands

    Upper Band$191.19
    Lower Band$174.46
    %B Position915%(Upper)
    Band Width1.16

    RSI (14-Day)

    Neutral
    68.5

    Momentum Oscillators

    Stoch %K90.5
    Stoch %D88.3
    Williams %R-2.4
    ROC (10d)8.9%
    Momentum15.78
    CCI (20d)248.1
    MFI (14d)64.2

    Volatility Measures

    ATR (14d)$4.16(2.1%)
    StdDev (20d)4.18
    Hist Vol22.1%(Moderate)

    Volume Flow

    VWAP$192.55
    OBV-68.0M
    AD Line-12.4B
    CMF (20d)0.155

    Volume Metrics

    Avg Vol (20d)1.8M
    Vol Ratio1.1x
    VWMA (20d)$182.52

    Pivot Points

    R3$194.00
    R2$191.84
    R1$190.36
    Pivot Point$188.20
    S1$186.73
    S2$184.57
    S3$183.09

    Advanced Oscillators

    TSI15.12
    Ultimate Osc70.0
    KST3.97

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$4.98B$4.71B$5.25B$7.47B$4.73B$4.48B$5.17B$5.44B$4.99B$5.04B$4.71B$5.09B
    Cost of Revenue$2.67B$2.56B$2.84B$3.87B$2.49B$2.62B$2.93B$2.95B$2.68B$2.74B$2.68B$3.38B
    Gross Profit$2.31B$2.15B$2.41B$3.59B$2.23B$1.86B$2.23B$2.49B$2.31B$2.30B$2.03B$1.70B
    Operating Expenses$1.65B$2.06B$1.86B$2.59B$1.50B$1.48B$1.78B$1.86B$1.71B$1.57B$1.59B$1.35B
    R&D$258.00M$249.00M$306.00M$460.00M$230.00M$232.00M$343.00M$302.00M$299.00M$299.00M$290.00M$281.00M
    SG&A$1.26B$1.21B$1.39B$1.68B$1.16B$1.12B$1.32B$1.25B$1.20B$1.19B$1.21B$1.14B
    Operating Income$663.00M$93.00M$552.00M$1.00B$739.00M$383.00M$453.00M$622.00M$602.00M$734.00M$439.00M$349.00M
    Interest Income$4.00M$9.00M$4.00M$6.00M$4.00M$5.00M$23.00M$55.00M$48.00M$26.00M$34.00M$9.00M
    Interest Expense$132.00M$149.00M$153.00M$156.00M$152.00M$150.00M$155.00M$155.00M$137.00M$125.00M$111.00M$113.00M
    Income Before Tax$554.00M$39.00M$393.00M$805.00M$569.00M$201.00M$306.00M$513.00M$500.00M$633.00M$359.00M$181.00M
    Income Tax Expense$102.00M$76.00M$11.00M$39.00M$118.00M$43.00M$3.00M$114.00M$13.00M$96.00M$77.00M$28.00M
    Net Income$377.00M$-311,000,000$382.00M$493.00M$574.00M$308.00M$303.00M$400.00M$487.00M$537.00M$281.00M$108.00M
    EBITDA$1.25B$699.00M$1.16B$1.71B$1.29B$871.00M$1.04B$1.20B$1.16B$1.30B$996.00M$873.00M
    EBIT$682.00M$179.00M$542.00M$955.00M$717.00M$347.00M$437.00M$613.00M$589.00M$732.00M$435.00M$286.00M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about BDX

    News

    Mizuho lifts target for Haemonetics stock to USD 140.00 with 15.57 percent upside opportunity

    Mizuho analyst Anthony Petrone raised the price target for Haemonetics (HAE) stock to USD 140.00 from USD 95.00...

    ad-hoc-news.de•10/15/26•Neutral

    Barclays sets USD 165.00 target for Becton Dickinson stock

    Barclays has set a USD 165.00 target for Becton Dickinson (BDX) stock. The company is set to report its fourth-quarter results on November 5, 2026...

    ad-hoc-news.de•10/15/26•Somewhat-Bullish

    Mizuho lifts target for ResMed stock to USD 240.00

    Mizuho has increased its price target for ResMed stock from USD 235.00 to USD 240.00, while maintaining an Outperform rating. ResMed Inc. (RMD) is set to report its first-quarter fiscal 2027 results on October 29, 2026...

    ad-hoc-news.de•10/15/26•Somewhat-Bullish

    OraSure Technologies stock trades above USD 3.00 consensus target

    OraSure Technologies stock is trading above its USD 3.00 consensus target, despite the target being 21.47 percent below its Nasdaq quote. The company reported improved second-quarter margins with revenue of USD 30.64...

    ad-hoc-news.de•10/15/26•Neutral

    Mizuho lifts target for Haemonetics stock to USD 140.00 with 15.57 percent upside opportunity

    Mizuho analyst Anthony Petrone has raised the price target for Haemonetics (HAE) stock to USD 140.00 from USD 95.00...

    ad-hoc-news.de•10/15/26•Neutral

    BDX Valuation and Fair Value

    P/E
    14.9x
    Forward P/E
    13.7x
    EV/EBITDA
    14.3x
    P/FCF
    16.5x
    PEG
    1.1x
    P/B
    2.2x
    See GNG's fair value

    BDX Profitability: Margins, ROIC and FCF

    Gross margin
    46.7%
    Operating margin
    15.7%
    Net margin
    4.2%
    ROIC
    5.0%
    ROE
    6.6%
    FCF margin
    14.3%
    FCF yield
    6.1%

    BDX Competitors

    CompanyTicker
    Natera IncNTRA
    Humana IncHUM
    Cardinal Health IncCAH
    argenx NV ADRARGX
    Takeda Pharmaceutical Co Ltd ADRTAK
    Edwards Lifesciences CorpEW
    Boston Scientific CorpBSX
    Agilent Technologies IncA

    Sector: Healthcare

    BDX Analyst Ratings

    Consensus
    Buy
    Analysts
    14
    Strong Buy
    1
    Buy
    6
    Hold
    7
    Sell
    0
    Strong Sell
    0

    BDX Bull Case vs Bear Case

    Bull case

    • BDX beat EPS estimates in 100.0% of its last 8 reported quarters.

    BDX Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    4.8%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $3.90

    BDX Dividend

    Forward yield
    2.2%
    Payout ratio
    27.4%
    3Y DPS growth
    5.8%
    5Y DPS growth
    5.4%
    Pay months
    Mar, Jun, Sep, Dec
    BDX dividend history

    Frequently Asked Questions About BDX

    What is BDX's current dividend yield?

    Becton Dickinson and Company (BDX) has a forward dividend yield of 2.17%.

    Does BDX pay dividends?

    Yes, Becton Dickinson and Company pays dividends with a forward dividend yield of 2.17%.

    What is BDX's P/E ratio?

    Becton Dickinson and Company has a price-to-earnings (P/E) ratio of 14.91.

    What is BDX's market cap?

    Becton Dickinson and Company (BDX) has a market capitalization of $51.45B with a current stock price of $193.85.

    Related stocks

    Sector: Healthcare

    All stocks starting with B

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In